How Does a Stroke Affect the Heart?

A stroke is a brain event, but it can inflict real, measurable damage on the heart within hours. The brain and heart are connected through the autonomic nervous system and shared hormonal pathways, and when a stroke disrupts those pathways, the heart often pays a price. Cardiac complications after stroke are common enough that researchers now use the term “stroke-heart syndrome” to describe the full spectrum of heart changes that follow a stroke, from abnormal heart rhythms and enzyme spikes to a temporary form of heart failure that can mimic a heart attack.

The Catecholamine Storm

The primary way a stroke damages the heart is through a massive, sudden release of stress hormones called catecholamines, particularly norepinephrine and epinephrine. When a stroke injures the brain, the sympathetic nervous system goes into overdrive. The hypothalamic-pituitary-adrenal axis activates, flooding the bloodstream and the nerve endings inside the heart muscle itself with catecholamines at toxic levels.¹ This is not just a brief spike. Catecholamine levels can stay elevated for days, and that prolonged exposure is directly toxic to heart muscle cells.

At the cellular level, the catecholamine surge causes a specific type of damage called contraction-band necrosis, where individual muscle fibers in the heart are essentially forced into a locked contraction and die. One study found contraction-band necrosis in roughly half of patients who died after an ischemic stroke and in nearly nine out of ten patients after a subarachnoid hemorrhage, compared with about a quarter of patients who died from non-brain-related causes.¹ The difference is stark: the brain injury itself is driving heart muscle destruction through this hormonal pathway.

Alongside the catecholamine storm, stroke triggers a systemic inflammatory response. The combination of autonomic dysfunction and widespread inflammation disrupts the normal metabolism of heart muscle cells, compounding the direct toxic effects of the stress hormones.² In subarachnoid hemorrhage specifically, researchers have found that the inflammatory response involves a surge of immature immune cells that release pro-inflammatory molecules, and this inflammatory environment is itself linked to cardiac dysfunction and worse outcomes.³

Why Stroke Location Matters for the Heart

Not all strokes hit the heart equally hard. The insular cortex, a region buried deep within the brain’s lateral surface, plays a central role in regulating the autonomic nervous system. When a stroke damages the insula, the resulting cardiac complications tend to be more severe. Research has shown that sympathetic nervous system activity is significantly higher in patients whose stroke involves the insular cortex compared with strokes in other brain regions.⁴

There is also a striking difference between the left and right sides of the brain. The right insular cortex appears to be the dominant regulator of sympathetic tone, and patients with right-hemisphere strokes involving the insula show the most extreme cardiac autonomic disruption. These patients develop more complex arrhythmias than patients with strokes in other locations, and their heart-rate variability drops significantly, a sign that the heart has lost much of its normal regulatory flexibility.⁵ Even early research on stroke and cardiac arrhythmias found that patients with cerebral hemisphere strokes had significantly more arrhythmias than those with brainstem strokes.⁶

Subarachnoid hemorrhage, a type of stroke caused by bleeding on the brain’s surface, tends to produce especially severe cardiac effects. Patients who have elevated markers of heart muscle damage at the time of admission after subarachnoid hemorrhage face roughly double the mortality rate compared with those whose markers are normal.⁷

Troponin Elevation After Stroke Is Not Always a Heart Attack

One of the most confusing aspects of stroke-heart syndrome for patients and even for clinicians is the rise in cardiac troponin, the blood protein that is the gold standard marker for heart muscle injury. Among patients admitted with acute ischemic stroke, roughly one in seven has elevated troponin levels.⁸ In traditional cardiology, elevated troponin almost always means blocked coronary arteries, so the natural instinct is to suspect a simultaneous heart attack.

But when researchers actually performed coronary angiography on stroke patients with elevated troponin in the TRELAS study, the picture was very different from what you would see in a typical heart-attack patient. Coronary culprit lesions, the artery blockages that cause classic heart attacks, were found in only about a quarter of stroke patients, compared with roughly four out of five patients who came in with a standard acute coronary syndrome. Half of the stroke patients with elevated troponin had no significant coronary artery disease at all.⁸ The heart damage, in other words, is real but is not caused by blocked arteries. It is caused by the catecholamine-driven injury from the brain itself.

This distinction has practical consequences. A troponin rise after stroke does not automatically mean the patient needs the same urgent interventions used for a traditional heart attack. But it is far from benign. Stroke patients whose troponin levels continue to climb after admission face dramatically higher short-term mortality. One study found that a rising troponin pattern was associated with a roughly 32-fold increase in the odds of dying within seven days, while patients whose troponin fell or remained stable did not face the same risk.⁹ Elevated troponin in ischemic stroke has also been independently linked to about a sixfold increase in overall mortality and roughly double the odds of a poor discharge outcome.¹⁰

Arrhythmias and ECG Changes

Heart rhythm disturbances are among the most common cardiac complications of stroke. A prospective study using continuous heart monitoring found that about a quarter of all stroke patients developed significant arrhythmias, with the highest risk concentrated in the first 24 hours after admission. Fast heart rhythms, including ventricular and rapid supraventricular arrhythmias, were more common than dangerously slow ones.¹¹

Beyond rhythm disturbances, stroke routinely produces characteristic changes on the electrocardiogram that can look alarmingly like heart disease. One of the most consistent findings is prolongation of the QT interval, a measurement of the heart’s electrical recovery time. At the time of stroke admission, nearly 60% of patients had a prolonged QT interval. This dropped to about 40% after 48 hours and roughly 15% at three months, suggesting the changes are driven by the acute brain injury rather than by underlying heart disease.¹² The more severe the stroke, the more pronounced the QT prolongation: it was present in nearly all patients with severe strokes. Other common ECG changes include ST-segment and T-wave abnormalities and sinus bradycardia, all of which tend to resolve as the acute phase passes.¹³

The fact that these changes were recognized decades ago but initially dismissed as “purely electrophysiologic alterations and not real heart disease” is worth noting. Research eventually demonstrated that some patients with these neurogenic ECG abnormalities also had cardiac enzyme release and actual structural damage to heart muscle fibers visible at autopsy.¹⁴ The ECG changes are not just electrical noise; they can reflect genuine injury.

Takotsubo Cardiomyopathy and Neurogenic Stress Injury

Perhaps the most dramatic example of the brain injuring the heart is takotsubo cardiomyopathy, sometimes called “broken heart syndrome.” In this condition, a surge of stress hormones causes a sudden, temporary weakening of the heart muscle, typically with a distinctive ballooning of the left ventricle’s tip. Takotsubo has long been associated with intense emotional stress, but stroke is a potent trigger as well. One study found it was “not a rare complication” of acute ischemic stroke, with cases appearing soon after stroke onset and often going undetected because the patient had no chest pain or other classic cardiac symptoms.¹⁵ Women and patients with insular cortex damage were disproportionately affected.

Researchers now use the broader term “neurogenic stress cardiomyopathy” to describe this stroke-specific form of takotsubo, highlighting that the cause is neurological rather than emotional.¹⁶ The damage from neurogenic stress cardiomyopathy is usually reversible, but not always. In some patients, the acute heart dysfunction progresses to lasting cardiac impairment.¹⁷ And even temporary heart dysfunction during the critical early days of a stroke can reduce blood flow to the already-damaged brain, creating a vicious cycle.

Women Face Higher Risk of Stroke-Related Heart Injury

Sex differences in stroke-heart syndrome are real and clinically meaningful. In a study of stroke patients who had elevated troponin at baseline, women were twice as likely as men to develop acute myocardial injury following their stroke. Women in the study were older and had lower rates of traditional cardiovascular risk factors like high cholesterol or prior heart disease. They also more frequently had cardioembolic strokes and right insular involvement, both of which, as described earlier, carry greater cardiac risk. Patients who developed post-stroke acute myocardial injury had more than five times the odds of dying within seven days.¹⁸

The finding is somewhat counterintuitive. Women in the study had fewer of the risk factors that would normally predispose someone to heart trouble, yet they were more vulnerable to the brain-driven form of cardiac injury. This pattern echoes what is seen in takotsubo cardiomyopathy more broadly, where postmenopausal women are the most common patients. The reasons are still under investigation, but hormonal differences and variations in autonomic nervous system reactivity likely play a role.

Long-Term Cardiovascular Risk After Stroke

The cardiac toll of stroke does not end when the acute phase is over. A three-year prospective study in central Norway found that the cumulative incidence of major adverse cardiovascular events after ischemic stroke was about 15%, with recurrent stroke being the most common vascular event. All-cause mortality over the same period was roughly 18%, and the cardiovascular risk was highest during the first year.¹⁹ Longer-term data paint a similar picture: one study estimated the cumulative incidence of major adverse cardiovascular events at about 13% within the first year and roughly 36% over the full follow-up period.²⁰

New-onset cardiovascular complications diagnosed in the wake of an ischemic stroke are very common and are linked to significantly worse outcomes over at least five years.²¹ This is not simply a matter of stroke patients being people who already had heart disease. Even when researchers adjust for pre-existing cardiovascular risk factors, the stroke itself adds an independent layer of cardiac risk. A decreased ejection fraction, for instance, is far more common in stroke patients than in matched controls. One multiethnic study found that any degree of left ventricular dysfunction was present in about 24% of stroke patients versus roughly 5% of controls, with an adjusted odds ratio of nearly four even after accounting for other risk factors.²²

Monitoring and Detecting Hidden Heart Problems

Because stroke can both cause and be caused by heart problems, the period after a stroke is a critical time for cardiac monitoring. One of the most important things doctors look for is atrial fibrillation, an irregular heart rhythm that is both a major cause of stroke and something that can emerge for the first time after one. Prolonged cardiac monitoring substantially improves detection of previously unrecognized atrial fibrillation in stroke patients and leads to earlier initiation of blood-thinning medication, which can prevent a second stroke.²³

The question of how long to monitor is still evolving. Current guidelines recommend at least three days of outpatient heart-rhythm monitoring after a stroke of unclear cause, but research suggests this minimum may not be enough. In one study, seven-day outpatient monitoring after ischemic stroke or transient ischemic attack detected new atrial fibrillation in about 5% of patients, with roughly half of first-detected episodes occurring on the first day but new cases still appearing up to day seven.²⁴ For some patients, even longer monitoring may be warranted. A 5% detection rate may sound modest, but each case represents someone who can be started on anticoagulation to prevent a potentially fatal second stroke.

What Can Be Done to Protect the Heart After Stroke

Given that much of the cardiac damage after stroke is driven by sympathetic overactivation, it makes sense that beta-blockers, drugs that blunt the effects of adrenaline on the heart, might help. A large observational study found that continued beta-blocker use in stroke patients who had elevated heart rates was associated with roughly a 20% reduction in long-term mortality, with benefits extending out to ten years.²⁵ This is not yet enough evidence to make beta-blockers a universal recommendation for every stroke patient, but it supports the idea that dampening the catecholamine storm can make a meaningful difference in the right patients.

On the rehabilitation side, there is growing recognition that stroke patients benefit from cardiac rehabilitation programs, the same structured exercise and risk-factor management programs traditionally reserved for heart-attack patients. With appropriate adaptations for neurological deficits like weakness or balance problems, cardiac rehab can improve cardiovascular fitness, promote functional recovery, and reduce future cardiovascular and cerebrovascular events in stroke survivors.²⁶ Despite this, stroke patients are far less commonly referred to cardiac rehab than heart-attack patients, largely because the connection between brain injury and heart risk has not fully penetrated standard practice.

The Bidirectional Problem

One reason stroke-heart syndrome is receiving more research attention is the recognition that the relationship between the brain and heart runs in both directions. Heart disease causes stroke: atrial fibrillation throws clots into the brain, a weak heart pumps sluggishly enough to promote clot formation, and atherosclerosis narrows both coronary and cerebral arteries. But the reverse arrow, stroke causing heart disease, is equally real and has been underappreciated.²⁷

The introduction of the term “stroke-heart syndrome” itself is relatively recent, reflecting an effort to give clinicians a unified framework for recognizing and managing the full range of cardiac complications that follow strokes.²⁸ The concept groups together the ECG changes, the troponin elevations, the arrhythmias, the stress cardiomyopathy, and the echo abnormalities that occur in the first month after stroke onset, recognizing them as part of a single pathological process rather than as unrelated coincidences. This reframing matters because it encourages neurologists to think about the heart and cardiologists to think about the brain, rather than each specialty treating its organ in isolation.

As researchers dig deeper into the mechanisms linking brain injury to cardiac damage, new therapeutic targets may emerge. The role of systemic inflammation, immature immune cell populations, and specific neurotransmitter pathways in driving post-stroke heart injury is only beginning to be mapped, and targeted immunomodulation is being explored as a possible intervention.³ For now, the practical takeaway is that a stroke is not just a brain problem. The heart is listening, and in many patients, it is hurting too.